Matching slides 110,355
Current window 65,191-65,220
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all

Component

65,191-65,220 of 110,355

filter-aware
17
Amounts in thousands, except per share data. Unaudited.Lordstown Motors | Results Presentation Deck | 23 slides · Lordstown Motors
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
21
Amounts in thousands.Lordstown Motors | Results Presentation Deck | 23 slides · Lordstown Motors
Conference presentation Investor relations 1 hit
10
The slide uses a numbered list format to present key performance indicators.Membership Collective Group | Results Presentation Deck | 32 slides · Membership Collective Group
Deck Investor relations 1 hit
17
Includes a footnote regarding non-GAAP financial measures.Membership Collective Group | Results Presentation Deck | 32 slides · Membership Collective Group
Deck Investor relations Beat · Appendix Data1 hit
05
The slide highlights a strategic shift toward larger, higher-rate loans.Mill City Ventures III | Results Presentation Deck | 10 slides · Mill City Ventures III, Ltd.
Deck Investor relations Beat · ProductLoop · Logic Chain1 hit
06
Includes a table of financial results and a list of operational commentary points.ModivCare | Results Presentation Deck | 18 slides · ModivCare
Conference presentation Investor relations 1 hit
07
The chart uses a standard waterfall bridge format to explain the movement in cash position.ModivCare | Results Presentation Deck | 18 slides · ModivCare
Conference presentation Investor relations 1 hit
08
Includes leverage metrics based on Consolidated Pro Forma Adj. EBITDA of $225.8 million plus synergies of $5.4 million.ModivCare | Results Presentation Deck | 18 slides · ModivCare
Conference presentation Investor relations 1 hit
11
Includes both GAAP financial metrics and operational KPIs like paid trips and average monthly members.ModivCare | Results Presentation Deck | 18 slides · ModivCare
Conference presentation Investor relations 1 hit
17
Standard financial disclosure slide for non-GAAP measures.ModivCare | Results Presentation Deck | 18 slides · ModivCare
Conference presentation Investor relations 1 hit
04
Includes four charts: two bar charts, one stacked bar chart, and one donut chart.Morgan Stanley | Fixed Income Presentation Deck | 11 slides · Morgan Stanley
Conference presentation Investor relations Beat · What IsLoop · Benchmark Gap1 hit
02
Slide contains redacted text blocks.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Situation & Context1 hit
12
The slide uses a dual-axis chart (price and volume) with callout boxes for specific dates and events.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Analogy1 hit
13
The chart shows Orange outperforming its peer groups and the S&P 500 since its IPO.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Evidence & ProofLoop · Analogy1 hit
17
Data as of 8/12/2022.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Evidence & Proof1 hit
19
The slide compares valuation multiples (AV/Revenue) against two different independent variables to assess the impact of FCF margin on valuation.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Evidence & Proof1 hit
22
The slide uses a DCF-based valuation approach to derive share price, discounting back from Dec 2024 to Aug 2022.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
24
Transaction data as of August 2022; excludes withdrawn deals.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
30
The chart displays the count of weeks falling into specific percentage change buckets.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
35
The slide demonstrates a consistent pattern of outperforming market expectations.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
37
The slide presents a multi-year financial forecast (CY19A-CY25E) including revenue, EBITDA, EBIT, and various cash flow line items.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & ApproachLoop · Mece Breakdown1 hit
06
Uses a bar chart visualization to represent patient population segments.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
07
The slide uses icons to represent four distinct pillars of growth: product profile, market synergy, financial milestone, and strategic pipeline expansion.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
09
Includes citations for data points.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide uses a timeline-based process diagram to illustrate the clinical trial structure.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
12
Clinical trial data presentation with p-values and sample sizes.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
13
The slide includes a footnote defining the response rate criteria and a disclaimer that it is not for promotion.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
15
The slide highlights a 49.7% reduction in NMPP NRS score at week 24 for the pooled MYFEMBREE group compared to 36.0% for placebo.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
16
The chart highlights a 57.9% mean reduction in pain domain score for the pooled MYFEMBREE group versus 32.6% for placebo at week 24.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
17
The chart shows a greater reduction in pain scores for the treatment group compared to placebo, with p < 0.05 significance indicated for both trials.Myovant Sciences | Results Presentation Deck | 34 slides · Myovant Sciences
Conference presentation Investor relations Loop · Before After1 hit